Literature DB >> 26497425

Surface-Engineered Viral Vectors for Selective and Cell Type-Specific Gene Delivery.

Christian J Buchholz1, Thorsten Friedel2, Hildegard Büning3.   

Abstract

Recent progress in gene transfer technology enables the delivery of genes precisely to the application-relevant cell type ex vivo on cultivated primary cells or in vivo on local or systemic administration. Gene vectors based on lentiviruses or adeno-associated viruses can be engineered such that they use a cell surface marker of choice for cell entry instead of their natural receptors. Binding to the surface marker is mediated by a targeting ligand displayed on the vector particle surface, which can be a peptide, single-chain antibody, or designed ankyrin repeat protein. Examples include vectors that deliver genes to specialized endothelial cells or lymphocytes, tumor cells, or particular cells of the nervous system with potential applications in gene function studies and molecular medicine.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AAV vector; cell entry receptor; directed evolution; lentiviral vector; rational design; surface display

Mesh:

Substances:

Year:  2015        PMID: 26497425     DOI: 10.1016/j.tibtech.2015.09.008

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  46 in total

Review 1.  Improving Molecular Therapy in the Kidney.

Authors:  Jeffrey D Rubin; Michael A Barry
Journal:  Mol Diagn Ther       Date:  2020-08       Impact factor: 4.074

Review 2.  Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.

Authors:  Devan L Puhl; Anthony R D'Amato; Ryan J Gilbert
Journal:  Brain Res Bull       Date:  2019-06-05       Impact factor: 4.077

3.  For the Success of Oncolytic Viruses: Single Cycle Cures or Repeat Treatments? (One Cycle Should Be Enough).

Authors:  Stephen J Russell
Journal:  Mol Ther       Date:  2018-07-18       Impact factor: 11.454

Review 4.  CRISPR, Prime Editing, Optogenetics, and DREADDs: New Therapeutic Approaches Provided by Emerging Technologies in the Treatment of Spinal Cord Injury.

Authors:  Vera Paschon; Felipe Fernandes Correia; Beatriz Cintra Morena; Victor Allisson da Silva; Gustavo Bispo Dos Santos; Maria Cristina Carlan da Silva; Alexandre Fogaça Cristante; Stephanie Michelle Willerth; Florence Evelyne Perrin; Alexandre Hiroaki Kihara
Journal:  Mol Neurobiol       Date:  2020-01-11       Impact factor: 5.590

5.  In Vivo Gene Delivery to Lymph Node Stromal Cells Leads to Transgene-specific CD8+ T Cell Anergy in Mice.

Authors:  Séverine Ciré; Sylvie Da Rocha; Maxime Ferrand; Mary K Collins; Anne Galy
Journal:  Mol Ther       Date:  2016-08-26       Impact factor: 11.454

6.  A simple approach for measuring FRET in fluorescent biosensors using two-photon microscopy.

Authors:  Richard N Day; Wen Tao; Kenneth W Dunn
Journal:  Nat Protoc       Date:  2016-09-29       Impact factor: 13.491

7.  Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature.

Authors:  Roshank Ahani; Farzin Roohvand; Reza Ahangari Cohan; Mohammad Hossein Etemadzadeh; Nasir Mohajel; Mahdi Behdani; Zahra Shahosseini; Navid Madani; Kayhan Azadmanesh
Journal:  Mol Biotechnol       Date:  2016-11       Impact factor: 2.695

8.  A computational analysis of pro-angiogenic therapies for peripheral artery disease.

Authors:  Lindsay E Clegg; Feilim Mac Gabhann
Journal:  Integr Biol (Camb)       Date:  2018-01-22       Impact factor: 2.192

9.  Intravital microscopy of biosensor activities and intrinsic metabolic states.

Authors:  Seth Winfree; Takashi Hato; Richard N Day
Journal:  Methods       Date:  2017-04-21       Impact factor: 3.608

10.  Combining T-cell-specific activation and in vivo gene delivery through CD3-targeted lentiviral vectors.

Authors:  Annika M Frank; Angela H Braun; Lea Scheib; Shiwani Agarwal; Irene C Schneider; Floriane Fusil; Séverine Perian; Ugur Sahin; Frederic B Thalheimer; Els Verhoeyen; Christian J Buchholz
Journal:  Blood Adv       Date:  2020-11-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.